We believe that this is a strength of this study, because here we highlight for the first time that IPAF reclassification can be clinically relevant when a diagnosis of IPF has been made, having prognostic implications that may potentially alter management. This evidence concerns the gene NLRC4 and idiopathic pulmonary fibrosis.